Cases
Ampio Pharmaceuticals, Inc. (AMPE)
Securities Class Action
Overview
Overview
- Date:
- 9/5/2019
- Company Name:
- Ampio Pharmaceuticals, Inc.
- Stock Symbol:
- AMPE
- Class Period:
- FROM 12/14/2017 TO 8/7/2018
- Status:
- Closed/Complete
- Court:
- U.S. District Court: Central California
NEW YORK, September 5, 2018 - According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the FDA would find Ampio's AP-003-C Phase 3 clinical trial inadequate and not well-controlled; (2) as a result, Ampio had not successfully completed two pivotal clinical trials for Ampio; (3) consequently, Defendants' public statements were materially false and misleading at all relevant times.